Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call

Endo, Inc. Pennsylvania Ireland

under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.). Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.

About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

Logo - https://mma.prnewswire.com/media/2621082/Endo_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/endo-reschedules-release-of-fourth-quarter-and-full-year-2024-earnings-results-and-conference-call-302397517.html